Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides

Journal of Lipid Research

Volumn 45, Issue 8, 2004, Pages 1446-1458

  Le Quéré, Valérie ^a   Plée Gautier, Emmanuelle ^a   Potin, Philippe ^b   Madec, Stéphanie ^b   Salaün, Jean Pierre ^b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b CNRS   (France)

Author keywords

Cytochrome P450; Epoxyeicosatrienoic acid; Hydroxylation; Leukotoxin; Liver; Microsomes; Oxylipin; Recombinant cytochrome P450

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450F3; EPOXIDE; EPOXYICOSATRIENOIC ACID; LEUKOTOXIN; LEUKOTRIENE B4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CATALYSIS; CHIRALITY; CLINICAL ARTICLE; COMPETITIVE INHIBITION; ENZYME INACTIVATION; EPOXIDATION; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN TISSUE; HYDROXYLATION; ICOSANOID METABOLISM; LIVER MICROSOME; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADULT; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; EPOXY COMPOUNDS; EXOTOXINS; FATTY ACIDS; FEMALE; HUMANS; MALE; MICROSOMES, LIVER; STEARIC ACIDS;

EID: 3442899024     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300463-JLR200     Document Type: Article

References (47)

1. Moran, J. H., L. A. Mitchell, J. A. Bradbury, W. Qu, D. C. Zeldin, R. G. Schnellmann, and D. F. Grant. 2000. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s. Toxicol. Appl. Pharmacol. 168: 268-279.
2. Kato, T., Y. Yamaguchi, T. Hirano, T. Yokoyama, T. Uyehara, T. Namai, S. Yamanaka, and N. Harada. 1984. Unsaturated hydroxy fatty acids, the self defensive substances in rice plant against rice blast disease. Chem. Lett. 26: 409-412.
3. Schweizer, P., A. Jeanguenat, D. Whitacre, J. P. Métraux, and E. Mösinger. 1996. Induction of resistance in barley against Erysiphe graminis f.sp. hordei by free cutin monomers. Physiol. Mol. Plant Pathol. 49: 103-120.
4. Mumby, S. M., and B. D. Hammock. 1979. A partition assay for epoxide hydrases acting on insect juvenile hormone and an epoxide-containing juvenoid. Anal. Biochem. 92: 16-21.
5. Jansen, M., A. J. Baars, and D. D. Breimer. 1986. Microsomal and cytosolic epoxide hydrolase in Drosophila melanogaster. Biochem. Pharmacol. 35: 2229-2232.
6. Zheng, J., C. G. Plopper, J. Lakritz, D. H. Storms, and B. D. Hammock. 2001. Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome. Am. J. Respir. Cell Mol. Biol. 25: 434-438.
7. Chu, I., D. C. Villeneuve, E. R. Nestmann, G. Douglas, G. C. Becking, R. Lough, and T. I. Matula. 1980. Subacute toxicity and mutagenicity of cis-9,10-epoxystearic acid. Bull. Environ. Contam. Toxicol. 25: 400-403.
8. Greene, J. F., K. C. Williamson, J. W. Newman, C. Morisseau, and B. D. Hammock. 2000. Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. Arch. Biochem. Biophys. 376: 420-432.
9. 2 elicitors. Plant Physiol. 117: 1373-1380.
10. Fang, X., T. L. Kaduce, N. L. Weintraub, S. Harmon, L. M. Teesch, C. Morisseau, D. A. Thompson, B. D. Hammock, and A. A. Spector. 2001. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J. Biol. Chem. 276: 14867-14874.
11. Laethem, R. M., M. Balazy, and D. R. Koop. 1996. Epoxidation of C18 unsaturated fatty acids by cytochromes P4502C2 and P4502CAA. Drug Metab. Dispos. 24: 664-668.
12. Draper, A. J., and B. D. Hammock. 2000. Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch. Biochem. Biophys. 376: 199-205.
13. Fahlstadius, P. 1988. Cis-9,10-epoxystearic acid in human leukocytes: isolation and quantitative determination. Lipids. 23: 1015-1018.
14. Capdevila, J. H., P. Mosset, P. Yadagiri, S. Lumin, and J. R. Falck. 1988. NADPH-dependent microsomal metabolism of 14,15-epoxyeicosatrienoic acid to diepoxides and epoxyalcohols. Arch. Biochem. Biophys. 261: 122-133.
15. Sevanian, A., R. A. Stein, and J. F. Mead. 1981. Metabolism of epoxidized phosphatidylcholine by phospholipase A2 and epoxide hydrolase. Lipids. 16: 781-789.
16. Ozawa, T., M. Hayakawa, K. Kosaka, S. Sugiyama, T. Ogawa, K. Yokoo, H. Aoyama, and Y. Izawa. 1991. Leukotoxin, 9,10-epoxy-12-octadecenoate, as a burn toxin causing adult respiratory distress syndrome. Adv. Prostaglandin Thromboxane Leukot. Res. 21B: 569-572.
17. Kolattukudy, P. E., T. J. Walton, and R. P. Kushwaha. 1973. Biosynthesis of the C18 family of cutin acids: omega-hydroxyoleic acid, omega-hydroxy-9,10- epoxystearic acid, 9,10,18-trihydroxystearic acid, and their delta12-unsaturated analogs. Biochemistry. 12: 4488-4498.
18. Totani, Y., Y. Saito, T. Ishizaki, F. Sasaki, S. Ameshima, and I. Miyamori. 2000. Leukotoxin and its diol induce neutrophil chemotaxis through signal transduction different from that of fMLP. Eur. Respir. J. 15: 75-79.
19. Dudda, A., G. Spiteller, and F. Kobelt. 1996. Lipid oxidation products in ischemic porcine heart tissue. Chem. Phys. Lipids. 82: 39-51.
20. Zeldin, D. C., C. R. Moomaw, N. Jesse, K. B. Tomer, J. Beetham, B. D. Hammock, and S. Wu. 1996. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch. Biochem. Biophys. 330: 87-96.
21. Daikh, B. E., J. M. Lasker, J. L. Raucy, and D. R. Koop. 1994. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J. Pharmacol. Exp. Ther. 271: 1427-1433.
22. Cowart, L. A., S. Wei, M. H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila. 2002. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands. J. Biol. Chem. 277: 35105-35112.
23. Li, P. L., D. X. Zhang, Z. D. Ge, and W. B. Campbell. 2002. Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 282: H1229-H1236.
24. Kozak, W., M. J. Kluger, A. Kozak, M. Wachulec, and K. Dokladny. 2000. Role of cytochrome P-450 in endogenous antipyresis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279: R455-R460.
25. Campbell, W. B., J. R. Falck, and K. Gauthier. 2001. Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor in bovine coronary arteries. Med. Sci. Monit. 7: 578-584.
26. Kroetz, D. L., and D. C. Zeldin. 2002. Cytochrome P450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol. 13: 273-283.
27. French, S. W., M. Morimoto, R. C. Reitz, D. Koop, B. Klopfenstein, K. Estes, P. Clot, M. Ingelman-Sundberg, and E. Albano. 1997. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J. Nutr. 127 (Suppl.): 907-911.
28. Miyazono, M., D. Zhu, R. Nemenoff, E. R. Jacobs, and E. P. Carter. 2003. Increased epoxyeicosatrienoic acid formation in the rat kidney during liver cirrhosis. J. Am. Soc. Nephrol. 14: 1766-1775.
29. Holla, V. R., F. Adas, J. D. Imig, X. Zhao, E. Price, Jr., N. Olsen, W. J. Kovacs, M. A. Magnuson, D. S. Keeney, M. D. Breyer, J. R. Falck, M. R. Waterman, and J. H. Capdevila. 2001. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. USA. 98: 5211-5216.
30. Kikuta, Y., E. Kusunose, T. Kondo, S. Yamamoto, H. Kinoshita, and M. Kusunose. 1994. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett. 348: 70-74.
31. Kikuta, Y., M. Kato, Y. Yamashita, Y. Miyauchi, K. Tanaka, N. Kamada, and M. Kusunose. 1998. Human leukotriene B4 omega-hydroxylase (CYP4F3) gene: molecular cloning and chromosomal localization. DNA Cell Biol. 17: 221-230.
32. Sontag, T. J., and R. S. Parker. 2002. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277: 25290-25296.
33. Christmas, P., S. R. Ursino, J. W. Fox, and R. J. Soberman. 1999. Expression of the CYP4F3 gene. Tissue-specific splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) omega-hydroxylase. J. Biol. Chem. 274: 21191-21199.
34. Zhang, X., and J. P. Hardwick. 2000. Regulation of CYP4F2 leukotriene B4 omega-hydroxylase by retinoic acids in HepG2 cells. Biochem. Biophys. Res. Commun. 279: 864-871.
35. Kikuta, Y., E. Kusunose, and M. Kusunose. 2002. Prostaglandin and leukotriene omega-hydroxylases. Prostaglandins Other Lipid Mediat. 68-69: 345-362.
36. Kikuta, Y., Y. Miyauchi, E. Kusunose, and M. Kusunose. 1999. Expression and molecular cloning of human liver leukotriene B4 omega-hydroxylase (CYP4F2) gene. DiVA Cell Biol. 18: 723-730.
37. Berthou, F., D. Ratanasavanh, C. Riche, D. Picart, T. Voirin, and A. Guillouzo. 1989. Comparison of caffeine metabolism by slices, microsomes and hepatocyte cultures from adult human liver. Xenobiotica. 19: 401-417.
38. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370-2378.
39. Pinot, F., J. P. Salaun, H. Bosch, A. Lesot, C. Mioskowski, and F. Durst. 1992. Omega-hydroxylation of Z9-octadecenoic, Z9,10-epoxystearic and 9,10-dihydroxystearic acids by microsomal cytochrome P450 systems from Vicia sativa. Biochem. Biophys. Res. Commun. 184:183-193.
40. Jin, R., D. R. Koop, J. L. Raucy, and J. M. Lasker. 1998. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch. Biochem. Biophys. 359: 89-98.
41. Christmas, P., J. P. Jones, C. J. Patten, D. A. Rock, Y. Zheng, S. M. Cheng, B. M. Weber, N. Carlesso, D. T. Scadden, A. E. Rettie, and R. J. Soberman. 2001. Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 276: 38166-38172.
42. Zeldin, D. C., C. R. Moomaw, N. Jesse, K. B. Tomer, J. Beetham, B. D. Hammock, and S. Wu. 1996. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch. Biochem. Biophys. 330: 87-96.
43. Fang, X., N. L. Weintraub, C. L. Oltman, L. L. Stoll, T. L. Kaduce, S. Harmon, K. C. Dellsperger, C. Morisseau, B. D. Hammock, and A. A. Spector. 2002. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am. J. Physiol. Heart Circ. Physiol. 283: H2306-H2314.
44. Palmer, C. N., T. H. Richardson, K. J. Griffin, M. H. Hsu, A. S. Muerhoff, J. E. Clark, and E. F. Johnson. 1993. Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid omega-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim. Biophys. Acta. 1172: 161-166.
45. Hoch, U., J. R. Falck, and P. R. de Montellano. 2000. Molecular basis for the omega-regiospecificity of the CYP4A2 and CYP4A3 fatty acid hydroxylases. J. Biol. Chem. 275: 26952-26958.
46. Street, J. M., J. E. Evans, and M. R. Natowicz. 1996. Glucuronic acid-conjugated dihydroxy fatty acids in the urine of patients with generalized peroxisomal disorders. J. Biol. Chem. 271: 3507-3516.
47. Powell, P. K., I. Wolf, R. Jin, and J. M. Lasker. 1998. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J. Pharmacol. Exp. Ther. 285: 1327-1336.